ICAM1 and glioblastoma: Greater fractions of KIR2DL1 NK cell clones that were KIR–HLA ligand mismatched against ICAM-1 expressing GBM cells expressed LFA-1 compared to bulk NK cells (P < 0.05, Figures 5E,F).